Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

COL6A1 Gene Bethlem Myopathy Next‑Generation Sequencing (Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل الجين COL6A1 لاعتلال بيتليم العضلي عبر التسلسل الجيني (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
  • Premium Logistics: Paid Hospital‑Grade Home Collection using ISO Certified Cold‑Chain transport; VIP Mobile Phlebotomy available.
  • Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
  • Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

يضمن هذا التحليل أعلى درجات الموثوقية عبر تقنية التسلسل المتقدمة وفق المعايير العالمية، مع خدمة سحب منزلي معتمدة من الآيزو.

Overview

The COL6A1 Gene NGS test identifies disease‑causing variants in the COL6A1 gene, confirming Bethlem myopathy – a slowly progressive hereditary neuromuscular disorder. This test provides definitive molecular diagnosis, guides clinical management, and enables informed family planning.

يكشف هذا الاختبار الطفرات الجينية المسببة لاعتلال بيتليم العضلي الوراثي، مما يمنح تشخيصاً جزيئياً قاطعاً ويدعم تخطيط الإدارة الطبية والعائلية.

Parameter Our Test (NGS) Closest Alternative (Single‑Gene Sanger)
Precision Comprehensive coding region coverage – detects single nucleotide variants, small indels, and copy number changes Limited to individual exons; missing large deletions/duplications
Method Next‑Generation Sequencing (NGS) with bioinformatic verification Sanger sequencing (gold standard for small variants, but narrower)
Turnaround Time 3–4 Weeks 6–8 Weeks

Physician Insight & Safety Protocol

Dr. PRABHAKAR REDDY (DHA License: 61713011) shares an empathetic note:

“As a neurologist, I recognise the emotional weight a genetic test carries. This analysis is a crucial step towards clarity, but results must always be correlated with your clinical picture and family history for a complete understanding.”

“Every genetic variation tells a story – our role is to interpret that story together, never in isolation.”

⚕️ Medication Warning: Do not discontinue any prescribed medication without consulting your doctor. Certain drugs and supplements may influence neuromuscular status; full disclosure before testing is essential.

Safety & Exclusion Criteria

  • Exclusion: Patients unable to give informed consent; minors without legal guardian authorisation; active systemic infection that could compromise sample integrity; non‑germline mosaic conditions requiring skin biopsy (blood‑based test not substitutive).
  • Red Flags (Seek Immediate Medical Attention): Sudden severe muscle weakness, respiratory difficulty, or swallowing impairment – these require emergency evaluation.

Regulatory Compliance:

This service is fully compliant with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE CDS Law 2026 (Minors), and UAE PDPL for genetic data privacy. Laboratory certified ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).

Patient FAQ & Clinical Guidance

What is the purpose of the COL6A1 Gene NGS test for Bethlem myopathy?

This test confirms a molecular diagnosis of Bethlem myopathy by sequencing the entire COL6A1 gene to identify disease‑causing mutations. يؤكد هذا الاختبار تشخيص اعتلال بيتليم العضلي عبر تحليل كامل جين COL6A1 للكشف عن الطفرات الممرضة.

How is the sample collected, and which specimens are acceptable?

A certified phlebotomist collects a whole blood sample for your convenience; alternatively, you can provide previously extracted DNA or a dried blood spot on an FTA card. يتم سحب عينة دم وريدي من قبل مختص معتمد، أو يمكن تقديم حمض نووي مستخلص أو بقعة دم جافة على بطاقة FTA.

What do the results mean for my family and treatment plan?

A positive result confirms the genetic cause and allows targeted surveillance and genetic counselling for at‑risk relatives; a negative result may require further investigation. النتيجة الإيجابية تؤكد السبب الجيني وتتيح مراقبة طبية موجهة وإرشاداً وراثياً للأقارب المعرضين للخطر.

Specimen: Whole Blood, Extracted DNA, or DNA FTA Card. Turnaround: 3–4 Weeks. Price: 2800 AED. Home collection available 8 AM‑11 PM daily. For insurance verification contact WhatsApp: +971 54 548 8731.

Pre‑ requirements: Genetic counselling session to draw a pedigree chart of family members affected with COL6A1 Gene Bethlem myopathy is mandatory. Clinical history documentation required.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians